NeurosciencebioRxivPreprint
In-vivo MRI of noradrenergic and dopaminergic nuclei predicts future cognition and Alzheimers disease progression
Wenhui Zhao, Samuel J Guzman, Hyun Joo Yoo…·Mara Mather
The paper uses in-vivo MRI to measure noradrenergic and dopaminergic nuclei integrity in ADNI participants, finding these measures predict future cognitive decline and Alzheimer's progression.